United Therapeutics Corp
UTHR
Revenue
748.90M
▲34.00M▲4.76%
3 Months ChangeAssets
7.12B
▲399.90M▲5.95%
3 Months ChangeLiabilities
1.02B
▼-3.80M▼-0.3704%
3 Months ChangeFree Cash Flow
338.30M
▲4.80M▲1.44%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001082554-24-000049
2024-10-30
Form 10-Q
ID: 0001082554-24-000047
2024-07-31
Form 8-K
ID: 0001082554-24-000037
2024-07-31
Form 10-Q
ID: 0001082554-24-000035
2024-06-27
Form 8-K
ID: 0001104659-24-075375
2024-05-01
Form 8-K
ID: 0001082554-24-000027
2024-05-01
Form 10-Q
ID: 0001082554-24-000025
2024-03-29
Form 8-K
ID: 0001104659-24-041160
2024-03-25
Form 8-K
ID: 0001104659-24-038478
2024-02-27
Form 8-K
ID: 0001104659-24-027791